SCHEMBL4291107

SCHEMBL4291107

COc1ccc(C(O)c2ccc(C)nc2OCc2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
MAPT P10636 1/20 0.45
LMNA P02545 3/20 0.44
HTT P42858 3/20 0.44
ALDH1A1 P00352 3/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CNR2 P34972 2/20 0.41
HPGD P15428 2/20 0.41
GAA P10253 2/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
TSHR P16473 3/20 0.41
MAPK1 P28482 2/20 0.41
GABRA1 P14867 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4294561 0.87 LMNA (0.42) CYP2D6CYP2C19MAPTLMNAHTT
SCHEMBL4279531 0.83 CYP1A2 (0.51) CYP1A2CYP2D6CYP2C19MAPTLMNA
SCHEMBL4289336 0.82 CNR2 (0.42) LMNAHTTALDH1A1NPSR1CNR2
SCHEMBL5381397 0.81 CYP1A2 (0.45) CYP1A2CYP2D6CYP2C19MAPTLMNA
SCHEMBL6377134 0.81 CYP1A2 (0.46) CYP1A2CYP2D6CYP2C19MAPTLMNA
SCHEMBL7744533 0.77 MAOB (0.51) CYP1A2CYP2D6CYP2C19MAPTLMNA
SCHEMBL2580792 0.76 FFAR1 (0.48) CYP1A2CYP2D6CYP2C19MAPTLMNA
SCHEMBL2579097 0.76 CYP1A2 (0.46) CYP1A2CYP2D6CYP2C19MAPTLMNA
SCHEMBL2576276 0.75 LMNA (0.52) CYP1A2CYP2D6CYP2C19MAPTLMNA
SCHEMBL5266803 0.75 LMNA (0.46) CYP1A2CYP2D6CYP2C19MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 CYP1A2 590/4885CYP2D6 212/4885CYP2C19 855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.